November 29, 2017—Silk Road Medical, Inc. announced data from the ROADSTER 1 and 2 trials demonstrating the safety and efficacy of the company’s Enroute transcarotid neuroprotection and Enroute transcarotid stent system, which are specifically designed and indicated for transcarotid artery revascularization (TCAR). The data were first presented at the 2017 VEITHsymposium, held November 14–18 in New York, New York.
Peter Schneider, MD, National Coprincipal Investigator of the ROADSTER 2 postmarket study of the Enroute system, commented in the company's announcement, “TCAR is the next step. Carotid endarterectomy has been perfected over 50 years, but no matter how good it gets, it has certain inherent challenges that aren’t ever going to go away. My attitude now has really flip-flopped from that of tried-and-true surgery to what I think is the future of carotid artery repair.”
Read More: http://evtoday.com/2017/11/updated-tcar-data-presented-from-silk-road-medicals-roadster-1-and-2-studies/
Via: Endovascular Today
OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings to Resume Chairman Responsibilities
Office of the President continues to perform the duties of President and CEO
Outset Medical Expands Senior Leadership Team by Adding Chief Operating Officer and Commercial Strategy VP
Via: Yahoo! Finance
Outset Medical, a commercial-stage company delivering new technology into the $13 billion global dialysis market, today announced the appointment of two new executives: Martin Vazquez, who joins the company as Chief Operating Officer, and Chad Hoskins as Vice President, Commercial and Corporate Strategy.
Q3 Cash Balance of $113.6M — Cash through Q3 2019
Diabetes is one of the most pervasive and expensive chronic diseases: It affects an estimated 30.3 million people in the United States and costs a staggering $245 billion per year to treat. In addition there are 84.1 million adults in the United States with high blood sugar levels in danger of developing type 2 diabetes. It is widely acknowledged that the most effective method of treating these prediabetics so they don’t become full-fledged diabetics is diabetes prevention programs (DPPs) that follow a protocol validated by the Centers for Disease Control and Prevention (CDC). But the challenge has been to get people to enroll in them in the first place and stick with them if they do.
Via: Union News Daily
SUMMIT, NJ — A new preventive procedure that is more accessible to seniors is now offered at Atlantic Health System’s Overlook Medical Center, helping patients to reduce the risk of stroke.
SUMMIT, NJ — Atlantic Health System’s Overlook Medical Center is the first hospital in New Jersey to offer an innovative new treatment for patients at risk for stroke due to blockages in the neck arteries, a condition known as carotid artery disease.
If we hope to be successful in a rapidly changing health care environment, dialysis providers can't afford to maintain the status quo. "Successful" doesn't just refer to financial stability; it also means providing good quality care for our patients.
Silk Road Medical Appoints World Class Stroke Prevention Champion to Serve as Vice President, Medical Affairs and Professional Education
Via: Business Insider
SUNNYVALE, Calif., Oct. 11, 2017 /PRNewswire/ -- Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, announces the appointment of Tammy Leitsinger to the position of Vice President, Medial Affairs and Professional Education. In this new role, Tammy will further develop and refine global, peer-to-peer TCAR training pathways and innovative educational programs.
Via: The Doctor Weighs In
In their own way, these 3 digital health tools streamline processes to improve efficiency—something we need much more of in healthcare.